title: [SEPTIC SHOCK IN PATIENT WITH SEVERE HEAD TRAUMA].
abstract: The clinical observation illustrates the role of screening of inflammatory markers and advanced hemodynamic monitoring in optimization of the treatment of the patient with severe traumatic brain injury (sTBI). The level of consciousness by the Glasgow Coma Scale at admission was 5 points. From the first day of stay the patient suffered hyperthermia to 39,0° C° The diagnosis of the aspiration pneumonia was determined by radiological signs, bronchoscopy and inflammatory blood markers, C-reactive protein, leukocytosis. From the second day the constant infusion of norepinephrine was necessary to maintain mean ABP above 80 mmHg. On the 10th day the patient's condition deteriorated sharply. Developed hyperthermia to 40, 2° and cardiovascular collapse (in spite of the high level of norepinephrine support a sharp decline in ABP up to 49/20 mmHg). Invasive advanced hemodynamic PiCCO monitoring (transpulmonary thermodilution) was started Septic shock was suspected. Standard laboratory tests did not meet the criteria for septic shock. Witnessed a slight increase in CRP and procalcitonin (PCT) was within normal limits. Diagnostic search was supplemented by a study of interleukins (IL-6 and IL-2R) in the blood plasma. The significant increase in their values, was regarded as the initial manifestations of the systemic inflammatory response. Sepsis was confirmed. The extended antibiotic therapy started Continuous Veno-Venous hemofiltration was used as part of treatment of the inflammatory-toxic condition. In two days of the therapy the patient's condition has stabilized, the patient recovered consciousness in the form of opening the eyes, simple instructions. At discharge, the patient's condition according to the Glasgow outcome scale was estimated at 4 points.
authors.forename: A A
authors.initials: AA
authors.lastname: Sichev
authors.forename: T Φ
authors.initials: TΦ
authors.lastname: Tabasaransky
authors.forename: I A
authors.initials: IA
authors.lastname: Savin
authors.forename: A S
authors.initials: AS
authors.lastname: Gorachev
authors.forename: V D
authors.initials: VD
authors.lastname: Tenedieva
authors.forename: T A
authors.initials: TA
authors.lastname: Abramov
authors.forename: A V
authors.initials: AV
authors.lastname: Oshorov
authors.forename: A A
authors.initials: AA
authors.lastname: Polupan
authors.forename: I V
authors.initials: IV
authors.lastname: Mazkovsky
authors.forename: A G
authors.initials: AG
authors.lastname: Gavrilov
authors.forename: A A
authors.initials: AA
authors.lastname: Potapov
mesh_terms: D000328:Adult; D020202:Cerebral Hemorrhage, Traumatic / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D006259:Craniocerebral Trauma / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D003937:Diagnosis, Differential; D006090:Gram-Negative Bacteria / Q000302:isolation & purification; D006801:Humans; D008297:Male; D009104:Multiple Trauma / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D012772:Shock, Septic / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D015599:Trauma Severity Indices; D016896:Treatment Outcome